Replacement of Lost Substance P Reduces Fibrosis in the Diabetic Heart by Preventing Adverse Fibroblast and Macrophage Phenotype Changes is a research paper published in Cells (2021). On theSindex it has a DataRank of 0. It has been cited 27 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: HL093215
National Institutes of Health
Grant: HL132908
National Institutes of Health
Grant: DK103616
George and Mary Thompson Fellowship
Grant: N/A
NIDDK NIH HHS
Grant: R01 DK103616
NHLBI NIH HHS
Grant: R00 HL093215
NHLBI NIH HHS
Grant: R01 HL132908
NHLBI NIH HHS
Grant: R56 HL132908
National Institutes of Health
Grant: 4R00HL093215-02
Neuro-immune Modulation of Cardiac Mast Cell-Mediated Myocardial Remodeling
National Institutes of Health
Grant: 5R01DK103616-03
Eicosanoid-based Therapy for Diabetes
National Institutes of Health
Grant: 5R01HL132908-02
Substance P: A central mediator of cardiac fibrosis and diastolic dysfunction
FWCI
2.01
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals